The disclosure generally relates to substituted heterocyclic compounds of Formula (Ia), which are inhibitors of PAD4, method for preparing these compounds, pharmaceutical compositions comprising these compounds and use of these compounds in the treatment of a disease or a disorder associated with PAD4 enzyme activity.
该披露通常涉及Formula (Ia)的取代
杂环化合物,这些化合物是PA
D4的
抑制剂,制备这些化合物的方法,包含这些化合物的药物组合物以及使用这些化合物治疗与PA
D4酶活性相关的疾病或障碍的方法。